Good-Loop
Good-Loop exists to make the internet a more positive place for brands, people and the world.
Good-Loop exists to make the internet a more positive place for everyone. Positive for brands by providing a platform to talk to customers in a respectful, positive and interactive environment. Positive for people who are empowered to take control of their online experiences, and to harness their own values as a force of good in the world. Positive for the world because when charities have a stable, sustainable source of income they have the security to plan longterm and the freedom to focus on maximising their positive impact.
Its purpose-powered advertising platform is a programmatic video, social and rich media solution that connects viewers and brands through ethical, high-quality formats. It does so by encouraging consumers to engage with online advertisements in exchange for 50% of the advertising revenue being diverted to a charity of the consumers’ choice.
The smart business model creates impact for brands by providing a platform to engage with consumers in a respectful, positive, and interactive environment – and consumers are empowered to take control of their online experiences and to harness their own values as a force for good; supporting causes that they care about.
Good-Loop supports positive social and / or environmental change by injecting a new source of funds into charities. With a more stable and sustainable source of income, charities have the security to plan for the longer term as well as the freedom to focus on maximising their positive impact.
Good-Loop has now raised considerable investment. It has demonstrated product market fit, delivering over £5m in revenue last year and is now looking to accelerate its growth into the US.
Related News
Beta Bugs secures £1.72m to scale up sustainable insect farming
Read more about Beta Bugs secures £1.72m to scale up sustainable insect farmingMicroplate Dx secures £2.5m to develop rapid antibiotic testing technology
Read more about Microplate Dx secures £2.5m to develop rapid antibiotic testing technology